ELAVL1 and thyroid gland carcinoma: In thyroid cancer, NPSR1-AS1 promotes malignant behavior by stabilizing NPSR1 mRNA through interaction with the RNA-binding protein ELAVL1 (ELAV Like RNA Binding Protein 1), leading to MAPK (Mitogen-activated protein kinase) pathway activation [68].